Hedge Fund - Perceptive Advisors
Amicus Therapeutics Inc. (FOLD)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q1 (2025-03-31) | $175,150,540 | 6.17% | 21,464,527 | $9.25 |
| 2 | 2024 - Q4 (2024-12-31) | $228,396,868 | 6.29% | 24,245,952 | $10.39 |
| 3 | 2024 - Q3 (2024-09-30) | $299,653,630 | 6.33% | 28,057,456 | $10.89 |
| 4 | 2024 - Q2 (2024-06-30) | $278,329,964 | 6.7% | 28,057,456 | $10.26 |
| 5 | 2024 - Q1 (2024-03-31) | $330,516,832 | 5.78% | 28,057,456 | $12.79 |
| 6 | 2023 - Q4 (2023-12-31) | $398,135,301 | 8.88% | 28,057,456 | $11.35 |
| 7 | 2023 - Q3 (2023-09-30) | $336,745,870 | 11.23% | 27,692,917 | $12.90 |
| 8 | 2023 - Q2 (2023-06-30) | $347,446,237 | 10.05% | 27,662,917 | $11.87 |
| 9 | 2023 - Q1 (2023-03-31) | $306,781,750 | 9.05% | 27,662,917 | $12.33 |
| 10 | 2022 - Q4 (2022-12-31) | $337,520,017 | 9.47% | 27,642,917 | $11.26 |
| 11 | 2022 - Q3 (2022-09-30) | $285,773,000 | 8.29% | 27,372,917 | $11.14 |
| 12 | 2022 - Q2 (2022-06-30) | $288,858,000 | 9.04% | 26,895,532 | $8.24 |
| 13 | 2022 - Q1 (2022-03-31) | $260,954,000 | 5.22% | 27,555,845 | $9.38 |
| 14 | 2021 - Q4 (2021-12-31) | $306,762,000 | 4.72% | 26,559,443 | $11.14 |
| 15 | 2021 - Q3 (2021-09-30) | $253,643,000 | 3.68% | 26,559,443 | $10.23 |
| 16 | 2021 - Q2 (2021-06-30) | $222,890,000 | 2.89% | 23,121,329 | $9.76 |
| 17 | 2021 - Q1 (2021-03-31) | $225,870,000 | 2.85% | 22,861,329 | $15.48 |
| 18 | 2020 - Q4 (2020-12-31) | $579,837,000 | 6.22% | 25,112,048 | $20.45 |
| 19 | 2020 - Q3 (2020-09-30) | $354,723,000 | 5.17% | 25,122,048 | $14.57 |
| 20 | 2020 - Q2 (2020-06-30) | $379,750,000 | 6.15% | 25,182,364 | $12.19 |
| 21 | 2020 - Q1 (2020-03-31) | $232,685,000 | 6.06% | 25,182,364 | $9.51 |
| 22 | 2019 - Q4 (2019-12-31) | $244,789,000 | 4.86% | 25,132,364 | $9.15 |
| 23 | 2019 - Q3 (2019-09-30) | $197,369,000 | 5.31% | 24,609,700 | $10.85 |
| 24 | 2019 - Q2 (2019-06-30) | $268,438,000 | 6.15% | 21,509,486 | $12.69 |
| 25 | 2019 - Q1 (2019-03-31) | $294,297,000 | 8.3% | 21,639,486 | $12.22 |
| 26 | 2018 - Q4 (2018-12-31) | $191,701,000 | 7.29% | 20,724,424 | $10.99 |
| 27 | 2018 - Q3 (2018-09-30) | $250,196,000 | 6.69% | 20,694,424 | $13.98 |
| 28 | 2018 - Q2 (2018-06-30) | $312,782,000 | 8.2% | 20,024,424 | $15.12 |
| 29 | 2018 - Q1 (2018-03-31) | $301,167,000 | 8.43% | 20,024,424 | $15.22 |
| 30 | 2017 - Q4 (2017-12-31) | $257,417,000 | 8.53% | 17,888,597 | $13.74 |
| 31 | 2017 - Q3 (2017-09-30) | $269,760,000 | 10.3% | 17,888,597 | $13.23 |
| 32 | 2017 - Q2 (2017-06-30) | $174,178,000 | 8.76% | 17,296,672 | $8.05 |
| 33 | 2017 - Q1 (2017-03-31) | $123,325,000 | 7.02% | 17,296,672 | $6.32 |
| 34 | 2016 - Q4 (2016-12-31) | $85,964,000 | 6.11% | 17,296,672 | $6.92 |
| 35 | 2016 - Q3 (2016-09-30) | $104,463,000 | 6.74% | 14,116,644 | $6.75 |
| 36 | 2016 - Q2 (2016-06-30) | $83,207,000 | 5.76% | 15,239,444 | $6.99 |
| 37 | 2016 - Q1 (2016-03-31) | $128,773,000 | 11.29% | 15,239,444 | $7.08 |
| 38 | 2015 - Q4 (2015-12-31) | $147,823,000 | 10.93% | 15,239,444 | $9.01 |
| 39 | 2015 - Q3 (2015-09-30) | $175,633,000 | 14.04% | 14,439,444 | $15.68 |
| 40 | 2015 - Q2 (2015-06-30) | $204,318,000 | 12.3% | 14,439,444 | $12.02 |
| 41 | 2015 - Q1 (2015-03-31) | $157,101,000 | 12.2% | 14,439,444 | $8.81 |
| 42 | 2014 - Q4 (2014-12-31) | $120,136,000 | 10.07% | 14,439,444 | $6.86 |
| 43 | 2014 - Q3 (2014-09-30) | $73,420,000 | 7.96% | 12,339,444 | $5.24 |
| 44 | 2014 - Q2 (2014-06-30) | $41,214,000 | 4.04% | 12,339,444 | $2.35 |
| 45 | 2014 - Q1 (2014-03-31) | $2,000,000 | 0.21% | 966,300 | $2.50 |
| 46 | 2012 - Q4 (2012-12-31) | $0 | 0% | 0 | $5.04 |
| 47 | 2012 - Q3 (2012-09-30) | $2,000 | 0% | 300 | $5.33 |
The displayed share prices are average quarterly stock market prices.